Ypsomed Holding AG - Asset Resilience Ratio
Ypsomed Holding AG (YPSN) has an Asset Resilience Ratio of 3.00% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2006–2024)
This chart shows how Ypsomed Holding AG's Asset Resilience Ratio has changed over time. Check Ypsomed Holding AG strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Liquid Assets Composition Over Time
This chart breaks down Ypsomed Holding AG's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Ypsomed Holding AG (YPSN) market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CHF36.30 Million | 3.0% |
| Short-term Investments | CHF0.00 | 0% |
| Total Liquid Assets | CHF36.30 Million | 3.00% |
Asset Resilience Insights
- Limited Liquidity: Ypsomed Holding AG maintains only 3.00% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Ypsomed Holding AG Industry Peers by Asset Resilience Ratio
Compare Ypsomed Holding AG's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Sartorius Aktiengesellschaft
XETRA:SRT3 |
Medical Instruments & Supplies | 0.26% |
|
Interojo Inc
KQ:119610 |
Medical Instruments & Supplies | 6.55% |
|
Crossject
PA:ALCJ |
Medical Instruments & Supplies | 1.31% |
|
Ocumetics Technology Corp
V:OTC |
Medical Instruments & Supplies | 0.00% |
|
I.Ceram SA
PA:ALICR |
Medical Instruments & Supplies | -1.61% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 7.53% |
|
Nanosonics Ltd
AU:NAN |
Medical Instruments & Supplies | 46.84% |
|
SDI Ltd
AU:SDI |
Medical Instruments & Supplies | 3.36% |
Annual Asset Resilience Ratio for Ypsomed Holding AG (2006–2024)
The table below shows the annual Asset Resilience Ratio data for Ypsomed Holding AG.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-03-31 | 0.05% | CHF575.00K ≈ $726.96K |
CHF1.10 Billion ≈ $1.39 Billion |
-0.03pp |
| 2023-03-31 | 0.09% | CHF746.00K ≈ $943.15K |
CHF861.88 Million ≈ $1.09 Billion |
-0.07pp |
| 2022-03-31 | 0.16% | CHF1.18 Million ≈ $1.49 Million |
CHF756.91 Million ≈ $956.94 Million |
-0.28pp |
| 2021-03-31 | 0.43% | CHF3.09 Million ≈ $3.91 Million |
CHF717.68 Million ≈ $907.35 Million |
-1.07pp |
| 2020-03-31 | 1.50% | CHF10.17 Million ≈ $12.86 Million |
CHF678.24 Million ≈ $857.48 Million |
+1.39pp |
| 2019-03-31 | 0.11% | CHF667.00K ≈ $843.27K |
CHF587.75 Million ≈ $743.07 Million |
-0.02pp |
| 2018-03-31 | 0.13% | CHF650.00K ≈ $821.78K |
CHF500.24 Million ≈ $632.44 Million |
-0.23pp |
| 2009-03-31 | 0.36% | CHF2.29 Million ≈ $2.90 Million |
CHF632.22 Million ≈ $799.29 Million |
-3.73pp |
| 2007-03-31 | 4.09% | CHF25.48 Million ≈ $32.21 Million |
CHF622.79 Million ≈ $787.37 Million |
-2.10pp |
| 2006-03-31 | 6.19% | CHF41.24 Million ≈ $52.14 Million |
CHF665.70 Million ≈ $841.62 Million |
-- |
About Ypsomed Holding AG
Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for safe and simple self-medication companies. The company operates through three segments: Ypsomed Delivery Systems, Ypsomed Diabetes Care, and Others. The Ypsomed Delivery Systems segment provides various injection systems, such as pen injectors, auto-injectors, and wearable inje… Read more